Importantly, increased levels of LAG-3highPD-1high memory CD4+ T cells was observed by immune profiling analysis in the peripheral blood of patients with CCA relapse after treatment with Gem plus CisPt, showing a better response to ABL501. This evidence concerns the gene CD4 and cholangiocarcinoma.